Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children.

    El-Din Elshazly LB, Youssef AM, Mahmoud NH, Ibrahim MM.

    Ital J Pediatr. 2009 Jul 20;35(1):22.

    PMID:
    19712439
    [PubMed - in process]
    Free PMC Article
    2.

    Nonstandard antibodies as prognostic markers in autoimmune hepatitis.

    Czaja AJ, Shums Z, Norman GL.

    Autoimmunity. 2004 May;37(3):195-201.

    PMID:
    15497452
    [PubMed - indexed for MEDLINE]
    3.

    Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis.

    Ballot E, Homberg JC, Johanet C.

    J Hepatol. 2000 Aug;33(2):208-15.

    PMID:
    10952238
    [PubMed - indexed for MEDLINE]
    4.

    A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.

    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.

    Hepatogastroenterology. 1997 Mar-Apr;44(14):417-25.

    PMID:
    9164512
    [PubMed - indexed for MEDLINE]
    5.

    Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.

    Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN.

    J Autoimmune Dis. 2007 Feb 4;4:2.

    PMID:
    17274827
    [PubMed]
    Free PMC Article
    6.

    Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.

    Czaja AJ, Donaldson PT, Lohse AW.

    Am J Gastroenterol. 2002 Feb;97(2):413-9.

    PMID:
    11866281
    [PubMed - indexed for MEDLINE]
    7.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    8.

    Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis.

    Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB.

    Hepatology. 1996 Nov;24(5):1068-73.

    PMID:
    8903377
    [PubMed - indexed for MEDLINE]
    9.

    Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis.

    Czaja AJ, Pfeifer KD, Decker RH, Vallari AS.

    Dig Dis Sci. 1996 Sep;41(9):1733-40.

    PMID:
    8794787
    [PubMed - indexed for MEDLINE]
    10.

    Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis.

    Czaja AJ, Shums Z, Norman GL.

    Autoimmunity. 2002 Dec;35(8):475-83.

    PMID:
    12765472
    [PubMed - indexed for MEDLINE]
    11.

    Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.

    Zachou K, Rigopoulou E, Dalekos GN.

    J Autoimmune Dis. 2004 Oct 15;1(1):2.

    PMID:
    15679907
    [PubMed - as supplied by publisher]
    Free PMC Article
    12.

    Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

    Czaja AJ, Carpenter HA, Manns MP.

    Gastroenterology. 1993 Nov;105(5):1522-8.

    PMID:
    8224657
    [PubMed - indexed for MEDLINE]
    13.

    Frequency and significance of antibodies to chromatin in autoimmune hepatitis type I.

    Li L, Chen M, Huang DY, Nishioka M.

    J Gastroenterol Hepatol. 2000 Oct;15(10):1176-82.

    PMID:
    11106099
    [PubMed - indexed for MEDLINE]
    14.

    Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics.

    Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler S, Cancado EL, Porta G, Nishioka M, Simon T, Daehnrich C, Schlumberger W, Galle PR, Lohse AW.

    Gut. 2002 Aug;51(2):259-64.

    PMID:
    12117891
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.

    Belloni C, Avanzini MA, De Silvestri A, Martinetti M, Pasi A, Coslovich E, Autelli M, Masanti ML, Cuccia M, Tinelli C, Rondini G, Lorini R.

    Pediatrics. 2002 Jul;110(1 Pt 1):e4.

    PMID:
    12093985
    [PubMed - indexed for MEDLINE]
    16.

    Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C.

    Bell TM, Bansal AS, Shorthouse C, Sandford N, Powell EE.

    J Gastroenterol Hepatol. 1999 May;14(5):419-22.

    PMID:
    10355504
    [PubMed - indexed for MEDLINE]
    17.

    Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis.

    Montano-Loza AJ, Shums Z, Norman GL, Czaja AJ.

    Liver Int. 2012 Jan;32(1):85-92. doi: 10.1111/j.1478-3231.2011.02502.x. Epub 2011 Mar 8.

    PMID:
    21745277
    [PubMed - in process]
    18.

    Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.

    Eyraud V, Chazouilleres O, Ballot E, Corpechot C, Poupon R, Johanet C.

    Liver Int. 2009 Jul;29(6):857-64. Epub 2009 Mar 2.

    PMID:
    19302185
    [PubMed - indexed for MEDLINE]
    19.

    Autoantibodies as prognostic markers in autoimmune liver disease.

    Czaja AJ.

    Dig Dis Sci. 2010 Aug;55(8):2144-61. Epub 2010 May 13. Review.

    PMID:
    20464491
    [PubMed - indexed for MEDLINE]
    20.

    Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.

    Johnson PJ, McFarlane IG, McFarlane BM, Williams R.

    J Gastroenterol Hepatol. 1990 May-Jun;5(3):244-51.

    PMID:
    2103405
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk